David Jaynee
Director/Board Member chez AURINIA PHARMACEUTICALS INC.
Fortune : 247 043 $ au 31/03/2024
Profil
David R.
W.
Jaynee is currently an Independent Director at Aurinia Pharmaceuticals, Inc. since 2015.
He is also a Professor at the University of Cambridge since 2017.
Additionally, he is a Member of the Immunopathology Working Group at ERA-EDTA.
Previously, he served as the First President of the European Vasculitis Society.
Dr. Jaynee completed his undergraduate degree at the University of Cambridge.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
23/05/2023 | 49 310 ( 0,03% ) | 247 043 $ | 31/03/2024 |
Postes actifs de David Jaynee
Sociétés | Poste | Début |
---|---|---|
AURINIA PHARMACEUTICALS INC. | Director/Board Member | 26/05/2015 |
University of Cambridge | Corporate Officer/Principal | 01/01/2017 |
ERA-EDTA | Corporate Officer/Principal | - |
Anciens postes connus de David Jaynee
Sociétés | Poste | Fin |
---|---|---|
European Vasculitis Society | President | - |
Formation de David Jaynee
University of Cambridge | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 2 |
---|---|
ERA-EDTA | |
European Vasculitis Society |